Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,385 EUR | +0,30% | +3,52% | -0,47% |
13/03 | Almirall tekent licentieovereenkomst met Eloxx Pharmaceuticals voor behandeling van huidziekten | MT |
19/02 | Transcript : Almirall, S.A., 2023 Earnings Call, Feb 19, 2024 |
Vakgebied
Aantal werknemers: 1 904
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Commercialization through Own Network
79,2
%
| 658 | 76,3 % | 709 | 79,2 % | +7,64% |
Commercialization through Licensees
9,9
%
| 87 | 10,0 % | 88 | 9,9 % | +1,97% |
Dermatology in the United States
6,4
%
| 74 | 8,6 % | 57 | 6,4 % | -22,50% |
Corporate Management and Results Not Assigned to Other Segments
4,5
%
| 44 | 5,1 % | 40 | 4,5 % | -9,15% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Spain
33,2
%
| 274 | 31,7 % | 297 | 33,2 % | +8,42% |
Germany
24,3
%
| 204 | 23,7 % | 218 | 24,3 % | +6,41% |
Europe and the Middle East
14,4
%
| 95 | 11,1 % | 129 | 14,4 % | +34,82% |
Italy
8,4
%
| 61 | 7,1 % | 75 | 8,4 % | +22,51% |
United States
6,4
%
| 74 | 8,6 % | 57 | 6,4 % | -22,50% |
America, Asia and Africa
5,4
%
| 52 | 6,0 % | 49 | 5,4 % | -6,61% |
France
4,8
%
| 35 | 4,1 % | 43 | 4,8 % | +21,32% |
United Kingdom
3,1
%
| 23 | 2,6 % | 28 | 3,1 % | +21,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 25-07-14 | |
Director of Finance/CFO | 54 | 11-11-19 | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 07-07-21 |
Volker Koscielny
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-19 |
Chief Operating Officer | - | 01-01-97 | |
Investor Relations Contact | - | - | |
Mercedes Diz
SAM | Sales & Marketing | - | 01-01-02 |
Isabel Gomes
LAW | General Counsel | - | 01-01-22 |
Paolo Cionini
PRN | Corporate Officer/Principal | - | - |
Human Resources Officer | - | 01-01-02 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 81 | 29-05-07 | |
Seth J. Orlow
BRD | Director/Board Member | - | 01-01-16 |
Eva-Lotta Allan
BRD | Director/Board Member | 65 | 01-07-20 |
Director/Board Member | 65 | 01-01-19 | |
Director/Board Member | 63 | 01-01-13 | |
Chief Executive Officer | - | 25-07-14 | |
Ruud Dobber
BRD | Director/Board Member | - | - |
Director/Board Member | - | 01-07-20 | |
Director/Board Member | - | 01-01-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 209 393 724 | 72 826 288 ( 34,78 %) | 0 | 34,78 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ALMIRALL, S.A. 1.28% | 2 690 101 | 1.28% | 24 012 380 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,47% | 1,87 mld. | |
+25,61% | 672 mld. | |
+25,87% | 570 mld. | |
-5,24% | 360 mld. | |
+16,49% | 321 mld. | |
+8,28% | 300 mld. | |
+7,09% | 217 mld. | |
-9,12% | 204 mld. | |
+5,01% | 199 mld. | |
-8,75% | 149 mld. |